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Abstract 
Heart disease is a major cause of morbidity and mortality throughout the world. Some 
cardiovascular conditions can be modulated by lifestyle factors such as increased exercise or 
a healthier diet, but many require surgical or pharmacological interventions for their 
management. More targeted and less invasive therapies would be beneficial. Recently it has 
become apparent that epicardial adipose tissue plays an important role in normal and 
pathological cardiac function, and it is now the focus of considerable research. Epicardial 
adipose tissue can be studied by imaging of various kinds, and these approaches have yielded 
much useful information. However at a molecular level it is more difficult to study as it is 
relatively scarce in animal models and, for practical and ethical reasons, not always available 
in sufficient quantities from patients. What is needed is a robust model system in which the 
interactions between epicardial adipocytes and cardiac myocytes can be studied, and 
physiologically relevant manipulations performed. There are drawbacks to conventional 
culture methods, not least the difficulty of culturing both cardiac myocytes and adipocytes, 
each of which has special requirements. We discuss the benefits of a three-dimensional co-
culture model in which in vivo interactions can be replicated. 
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Non-Standard abbreviations 
 
2D  2 dimensional 
3D  3-dimensional 
CAD  coronary artery disease 
CT  computer tomography 
EAT  epicardial adipose tissue 
EC-coupling excitation-contraction coupling 
FABP4 fatty-acid binding protein 4 
FDG-PET fluoro-deoxyglucose PET 
FFA  free fatty acid 
MRI  magnetic resonance imaging 
PET-CT positron-emission computer tomography 
RyR  ryanodine receptor 
SAT  superficial adipose tissue 
SR  sarcoplasmic reticulum 
TAG  triacylglycerols 
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Introduction 
The mammalian heart is surrounded by layers of visceral fat known as paracardial adipose 
tissue. The outermost layer of adipose tissue, the pericardial layer, can cover the entire 
structure and is separated from the surface of the heart by a layer of connective tissue, the 
fascia. Beneath this fascia, however, is another layer of fat that is directly apposed onto the 
heart, with no physical barrier between the two: the epicardial adipose tissue (EAT, see figure 
1). EAT is located primarily around cardiac blood vessels, in the atrio-ventricular cleft, and 
around the right ventricle; it can also extend into the myocardium and this is not in itself 
indicative of disease (Rabkin, 2007). Post-mortem studies have shown that EAT can cover 
80% of the heart and contribute up to 20% of ventricular mass in normal individuals (Rabkin, 
2007; Chechi et al., 2015). Epicardial adipocytes have many characteristics of white 
adipocytes, but produce UCP-1, a marker characteristic of brown adipocytes (Nicholls et al., 
1978; Sacks et al., 2009; Sacks et al., 2013). Thus some authors have described this tissue as 
‘beige’ or ‘brite’ (Gaborit et al., 2013; Chechi et al., 2015). 
 
The functional relationship between the heart and the overlying EAT is important; indeed the 
adipocytes within EAT, and their products, are critical to the function of the heart. Epicardial 
adipocytes are an essential source of free fatty acids, which cardiac myocytes preferentially 
utilise for energy (Marchington et al., 1989). EAT also provides thermal and physical 
protection for the heart (Rabkin, 2007; Chechi et al., 2015), and, importantly, is a rich source 
of adipokines which can interact with cardiac myocytes and other tissues in a paracrine 
manner to promote efficient cardiac function (Talman et al., 2014). However, these beneficial 
functions of EAT can be diminished or negated by the release of signals that evoke 
pathological changes in coronary blood vessels and cardiac myocytes. Thus there is interest 
in investigating interactions between EAT and the heart. Such studies could identify 
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clinically relevant processes or molecules that might allow pharmacological interventions for 
a range of cardiovascular diseases. 
 
Considerable work has shown that adipose tissue is biochemically specialised in a site-
specific way relating to its function (MacQueen et al., 2000; Mattacks et al., 2004; Westcott 
et al., 2006; Pond, 2009). There are clear and consistent differences in the triacylglycerol 
fatty acids found in adipocytes from different anatomical locations, even within the same 
adipose depot. Therefore it is not surprising that patterns of gene expression and proteins 
secreted also differ between adipocytes in a site-specific way. Zdychova et al. (2014) studied 
the secretome of adipocytes explanted and cultured from EAT, renal adipose tissue and 
superficial adipose tissue (SAT). Mazurek et al. (2003) were the first to show differences in 
cytokines secreted by EAT in patients with coronary artery disease (CAD), and found a 
higher number of pro-inflammatory cytokines secreted by the EAT. Compared to SAT, the 
transcriptome of the EAT is typical of that from an inflammatory tissue (McAninch et al., 
2015). Not only are the secretome and transcriptome different between SAT and EAT: 
Gaborit et al. (2015) have recently characterised molecular differences between various 
regions of the EAT (peri-ventricular, peri-coronary and peri-atrial). In general, pathological 
conditions such as CAD result in a downregulation of genes involved in intracellular 
trafficking, proliferation and protein catabolism, and an upregulation of genes involved in 
inflammatory and immune responses.  
 
The structure and function of EAT 
Epicardial fat is present from birth in humans and its mass increases with age until between 
20 and 40 years of age after which time it becomes independent of age (Rabkin, 2007). It is a 
dynamic fat depot, and can increase, or remodel, in conditions such as obesity and 
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inflammation (Hassan et al., 2012; Iacobellis, 2015; Kusayama et al., 2015; McAninch et al., 
2015; Matloch et al., 2016; Samanta et al., 2016). During development EAT arises from the 
splanchnopleural mesodermal lineage, the same origin as mesenteric and omental fat 
(Marchington et al., 1989; Gaborit et al., 2013), and it therefore shares the same lineage as 
cardiac myocytes (Martinsen et al., 2005). The two tissues are closely related in that they 
share circulation and innervation (Marchington et al., 1989; Arora et al., 2003). Intrinsic 
cardiac neurons and ganglionated plexuses, containing adrenergic and cholinergic neurons, 
are embedded in EAT (Arora et al., 2003; White, 2016). Zhou et al. (2014) showed that the 
cardiac ganglionated plexus in EAT incorporates the autonomic innervation (both 
sympathetic and parasympathetic) of the heart, and affects atrial function. Moreover, 
Balcioglu et al. (2015) found that a sympathovagal imbalance, a predictor of arrhythmia, was 
associated with EAT thickness. Parisi et al. (2016) also found that in patients with heart 
failure there was cardiac sympathetic denervation that could be correlated with increased 
epicardial adipocyte volume. EAT is not just a passive supporting structure for cardiac 
innervation, but is innervated in its own right. Zeng et al. (2015) have shown, although not in 
epicardial adipocytes, that sympathetic innervation of adipose tissue mediates the lipolytic 
action of leptin. Adipocytes from many sources have been shown to be sensitive to both β- 
and α- adrenergic stimulation, which directly increase lipolysis (Mattacks et al., 1999; 
Mattacks et al., 2005) thus providing an increased supply of free fatty acids for the heart’s 
energy requirements (see above).  
 
The thickness of EAT is a predictor for several types of cardiovascular disease signs such as 
stenosis, calcification, atheroma, stiffness, plaque development and arrhythmias including 
atrial fibrillation (Mookadam et al., 2010; Hassan et al., 2012; Gaborit et al., 2013; Hatem et 
al., 2014; Furuhashi et al., 2016; Siegel-Axel et al., 2016; Wong et al., 2016). Moreover 
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increased EAT volume is associated with a lengthened PR interval (Hung et al., 2015), 
suggesting that EAT can interfere with electrical conduction through the heart. Recently 
cognitive decline and dementia have also been linked to an increased EAT thickness 
(Mazzoccoli et al., 2014; Viscogliosi et al., 2016). However, EAT thickness varies between 
ethnicities, so no specific threshold value for clinical significance has yet been established 
(Willens et al., 2008; Pierdomenico et al., 2013; Yañez-Rivera et al., 2014). The relative 
amount of EAT varies between species. In general, larger mammals have more prominent 
EAT than smaller animals like rodents (Marchington et al., 1989). Recent studies have shown 
that mice possess a limited amount of EAT, located in the atrio-ventricular groove 
(Yamaguchi et al., 2015). Nevertheless it is difficult to obtain large amounts of EAT from 
rodents, limiting their use as a source of tissue for ex vivo and in vitro investigations. 
 
In common with other visceral fat depots, EAT has a function in lipid trafficking, and its 
mass is correlated with whole-body adiposity (Iacobellis et al., 2004). However, the mean 
adipocyte volume is around half the value found in other visceral adipose depots 
(Marchington et al., 1989) suggesting that the primary function of epicardial adipocytes is not 
fat storage. Moreover, even though the adipocytes in EAT can take up fatty acids from the 
circulation, convert them to triacylglycerols (TAG), and subsequently lipolyse and release 
them, these processes are not regulated by insulin in the same way as in adipocytes from 
other depots (Burgeiro et al., 2016): epicardial adipocytes are specialised for their role 
supporting heart muscle (Marchington et al., 1990). EAT is not simply a benign store of 
excess fat, since it is metabolically active and interacts with surrounding tissues, including 
the contractile cardiac myocytes within the heart (Gaborit et al., 2013). It is this last point that 
is the focus of our work, as we seek to understand how the metabolic activities of epicardial 
adipocytes support, or in pathological conditions dysregulate, cardiac myocyte function. The 
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metabolic cross-talk between EAT and the myocardium is poorly understood; nevertheless 
there is compelling evidence that it exists and is important in health and disease. Glucose 
uptake and lipid metabolism in EAT have been shown to be impaired in patients with heart 
failure, and these effects are modulated in patients who also had diabetes (Burgeiro et al., 
2016). There is a growing body of evidence of changes in gene expression in EAT that can be 
linked to cardiovascular disease (Salgado-Somoza et al., 2012; Agra et al., 2014a; Agra et al., 
2014b). This topic is extensive and has recently been systematically reviewed by Maghbooli 
et al. (2015). These authors concluded that the ‘hub’ genes for EAT involvement in 
cardiovascular disease were IL6 and p53; the latter gene was also identified as of major 
importance in coronary artery disease (Agra et al., 2014b). 
 
Like other cells that have a high demand for fatty acids (such as T cells containing a Gall 
body) cardiac myocytes contain fat droplets (Iozzo, 2011). It is thought that this sequestration 
of fatty acids allows them to be used rapidly when a physiological need arises. The particular 
mix of fatty acids sequestered varies with cell type and anatomical site (MacQueen et al., 
2000; Pezeshkian et al., 2009; Pond, 2009), and it would be interesting to measure the 
particular fatty acid mix found within cardiac myocytes and compare it with the fatty acid 
profiles of EAT. Burgeiro et al. (2016)  reported that the fatty acid composition of epicardial 
adipocytes is altered in patients with heart failure and diabetes, and this might suggest the 
existence of related changes in the fatty acid composition of cardiac myocytes in pathological 
states. 
 
Overview of adipokines 
It is well known that adipocytes secrete signalling molecules, and other factors that affect the 
cardiovascular system. Adipokines are frequently measured in the general circulation 
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(reviewed by Iacobellis, 2015) but these measurements cannot address the paracrine 
interactions that take place at a local level. It is not yet clear which of the cohort of paracrine 
messengers cause particular pathological changes in cardiac myocytes. Moreover, it has been 
demonstrated that the secretome of adipocytes can change under pathological conditions such 
as inflammation, thereby promoting the release of harmful signals (Kusayama et al., 2015; 
Venteclef et al., 2015; Furuhashi et al., 2016; Iacobellis, 2016). Adipokines have been linked 
to many pathologies (Deng et al., 2010b) but the mechanisms involved remain to be 
elucidated. 
 
The in vivo effects of adipokines are complex and not easily predictable. For example, the 
effects can be dose- or concentration-dependent, or may only become obvious if a particular 
combination of adipokines is present. As an example, the cardioprotective effect of omentin-1 
only becomes obvious when cardiac function is impaired, such as in diabetes mellitus 
(Greulich et al., 2013). Interestingly, the baseline adiponectin concentration in EAT is lower 
than that found in other fat depots (Elie et al., 2016), yet adiponectin can partially rescue the 
diminished cardiac contraction observed in obese mice (Dong et al., 2009). Both omentin-1 
and adiponectin are considered to be cardioprotective not only because of their direct effects 
on cardiac myocytes, but also because they reduce inflammation, improve endothelial 
function, and reduce oxidative stress (Gaborit et al., 2015; Matloch et al., 2016). The 
cardioprotective function of adrenomedullin is thought to originate in its vasodilative, anti-
inflammatory, and anti-oxidative effects, and in its inhibition of hypertrophic remodelling in 
a disease situation (Silaghi et al., 2007; Fosshaug et al., 2015). Some adipokines, such as 
resistin, activin A and FABP4 (Lamounier-Zepter et al., 2009; Look et al., 2011; Venteclef et 
al., 2015) have detrimental effects, whilst others, such as leptin and apelin, can show either 
helpful or deleterious effects depending on their concentration (Look et al., 2011; Ghantous 
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et al., 2015). As well as acting on myocytes, some adipokines have been shown to have an 
effect on cardiovascular endothelia: for example orosomucoid can increase proliferation in 
endothelial cells and therefore promotes healing of damaged endothelia (Fandino-Vaquero et 
al., 2014). It is unclear what provokes changes in the secretome of EAT to tip the balance 
between release of deleterious versus beneficial signals. However Fernandez-Trasancos et al. 
(2016) showed in vitro that inflammatory conditions, and glucose levels, affected adiponectin 
expression in EAT. The reported effects of a number of adipokines are summarised in Table 
1. 
 
EATing for a healthy heart 
EAT is critical for the function of a healthy heart by supplying free fatty acids (FFA) as the 
preferred energy source for cardiac myocytes, and by acting as a sink in case of an excess of 
circulating FFA. Nevertheless, much research has established that through its secretion of 
pro-inflammatory adipokines EAT is significantly associated with coronary artery disease 
and atherosclerosis (Shimabukuro et al., 2013; Talman et al., 2014; Furuhashi et al., 2016). 
In fact, EAT around the coronary vessels can co-localise with areas of plaque development 
(Prati et al., 2003; Alexopoulos et al., 2010). Peri-coronary EAT shows an upregulation of 
genes regulating sphingosine metabolism, suggesting a role for EAT in atherogenesis 
(Gaborit et al., 2015). While it is clear that compromised blood supply can interfere with 
heart function, our interest lies more with possible direct effects of EAT and its adipokines on 
the cardiac myocytes, and the disruption to regular beating that can result in arrhythmias such 
as atrial fibrillation.  
 
As noted above, EAT is a dynamic depot and its size is positively correlated with whole-body 
fat and obesity. Interestingly, changes in the structure and function of cardiac myocytes, and 
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the pro-inflammatory status of the adipocytes caused by a high fat diet can precede the onset 
of weight gain and obesity (Goncalves et al., 2016), and during weight loss protocols EAT 
reduces in thickness before abdominal fat is reduced (Iacobellis, 2015). This suggests that 
EAT activity is highly sensitive to nutritional status, and that epicardial adipocytes may act as 
a sentinel for cardiac dysfunction. 
 
Throughout a typical human lifetime the heart beats 2 million times (Bers, 2002). The 
contraction of the heart is triggered by action potentials that propagate from the sino-atrial 
node in the right atrial chamber. As an action potential sweeps across the atrial and 
ventricular chambers it causes the membrane to depolarise, thus opening voltage-operated 
calcium (Ca
2+
) channels and causing a Ca
2+
 influx into the cell. Within the cell, this Ca
2+
 
signal is amplified by Ca
2+
-induced Ca
2+
 release via ryanodine receptors (RyRs) on the 
sarcoplasmic reticulum (SR), thus causing a global Ca
2+
 signal that triggers the intracellular 
contractile machinery to engage, so that the cells shorten and generate the force to propel 
blood to the lungs and body. This process is often referred to as excitation-contraction 
coupling (EC-coupling; Berridge, 2003; Dobrzynski et al., 2013) and is illustrated in Figure 
2.  
 
For a regular heartbeat, each action potential must cause a rapid, transient, Ca
2+
 rise within 
every cardiac myocyte. It is believed that increased automaticity (spontaneous depolarisation 
of myocytes), acute triggered activity (spontaneous electrical events following recovery from 
an action potential) or re-entry circuits (return of an electrical impulse to cardiac cells 
following a refractory period) contribute to the development of arrhythmia. The underlying 
causes of all these pro-arrhythmic conditions are not fully understood, but substantial 
evidence has implicated a higher incidence of spontaneous Ca
2+
 signals as a likely cause 
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(Bers, 2008; Heijman et al., 2012; Voigt et al., 2012). Generally, pro-arrhythmic processes 
can be classified into electrical and structural remodelling. Electrical remodelling 
encompasses changes in the ion channel expression, changing the myocyte’s response to 
action potentials and leading to automaticity and triggered activity. Electrical remodelling can 
occur very rapidly, and is usually reversible. Recent evidence suggests that FFA can cause 
electrical remodelling in the atria (O'Connell et al., 2015). In contrast, structural remodelling 
takes longer to develop, and is usually irreversible. The most common structural remodelling 
process is fibrosis, the formation of fibrotic tissue between cardiac myocytes. As a 
consequence of fibrosis, the propagation of electrical signals is disrupted because of the 
presence of non-conducting tissue. Instead of propagating into the next cell, electrical signals 
spread sideways or backwards and can enter the same cell again, leading to the development 
of perpetuating rotors of electrical signals, and consequently to arrhythmia (Eisner, 2014; 
Heijman et al., 2014; Lip et al., 2016). Of interest here is the fatty infiltration between the 
cardiac myocytes, seen when excess EAT is present, that can transform into fibrotic tissue; 
adipokines and cytokines secreted from EAT can induce fibrosis (Haemers et al., 2015; 
Venteclef et al., 2015) and alter the Ca
2+
 handling, and thus the contractions, of cardiac 
myocytes (Hatem et al., 2016). It appears that the correct functioning of EAT is essential for 
effective cardiovascular activity, and the interactions between EAT and cardiac myocytes 
represent an important therapeutic target. 
 
Approaches to studying EAT  
EAT has historically been a somewhat neglected tissue (Rabkin, 2007) but the advent of 
techniques such as echocardiography made it easy to identify and quantify. Extensive work 
by Iacobellis and others (Iacobellis et al., 2003; Iacobellis et al., 2005; Iacobellis et al., 
2009b; Iacobellis et al., 2009a; McAninch et al., 2015; Elisha et al., 2016) showed that EAT 
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varies between individuals in thickness and volume, and the thickness can be correlated with 
disease states. For example, there is significantly more EAT in subjects with metabolic 
syndrome or coronary artery disease than in those without these conditions (Sade et al., 2009; 
Pierdomenico et al., 2013). The advantage of echocardiography is that it is non-invasive 
(though it may be coupled with more invasive techniques such as angiography), relatively 
cheap and widely available (Parisi et al., 2016); its disadvantage is that the studies are 
observational, giving a ‘snapshot’ of patients who have already presented with a suspected or 
actual cardiopathology. Also, using this technique it can be difficult to define the border 
between epicardial and pericardial fat, which can potentially generate misleading data (Hatem 
et al., 2016). Other fat depots which would be useful as controls are located in different parts 
of the body, so the appropriate controls can usually not be obtained from the same patient due 
to the increased risks and length of the necessary surgery (Fain et al., 2010; Gaborit et al., 
2015). One of the few prospective studies undertaken so far reported a correlation of peri-
atrial EAT thickness with the future onset of AF in patients who did not show any signs of 
AF at the time of the scan (Nakanishi et al., 2012). The reproducibility of echocardiographic 
analysis and interpretation has been questioned (Wong et al., 2016); nevertheless good 
correlation between echocardiography and other techniques for measuring EAT thickness in 
specific areas has been reported (Song do et al., 2015).  
 
Other types of imaging studies have been undertaken, such as computed tomography (CT) 
(Sarin et al., 2008; den Dekker et al., 2014; Harada et al., 2014; Hung et al., 2015; Kitagawa 
et al., 2015), positron-emission CT (PET-CT) (Janik et al., 2010; Bakkum et al., 2015), 
magnetic resonance imaging (MRI) (Kim et al., 2012; Gaborit et al., 2013; Hua et al., 2014) 
and FDG-PET (fluoro-deoxyglucose PET) (Kaushik et al., 2014; Mazurek et al., 2014). The 
principal advantage of all these methods is that they are non-invasive, and there is generally 
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much better resolution than in echocardiographic studies. Three-dimensional and volume 
measurements, rather than simply thickness, are possible: both CT and MRI can specifically 
measure peri-coronary EAT, which is an important correlate of atherosclerosis (Iacobellis, 
2016; Wong et al., 2016). CT studies have confirmed an association between atherosclerosis, 
myocardial infarction and EAT (Mahabadi et al., 2013; Mahabadi et al., 2014). However CT 
uses radiation, so is not suitable for follow-up studies requiring repeated measurements. The 
main drawback of these techniques is that they require expensive equipment and are neither 
cheap nor easy to access. This is particularly the case for cardiac MRI, regarded as the gold 
standard because it gives good 3D imaging, does not use radiation, and is the only method to 
have been verified ex vivo. MRI can reliably detect fibrosis and fat depots (Wong et al., 
2016). Therefore there is a trade-off between availability and accuracy when considering 
imaging methods. 
 
Post-mortem examination of patients who have died from other causes can provide some 
indications of the situation in ‘normal’ (albeit dead) individuals (Gho et al., 2014; Furuhashi 
et al., 2016). A drawback to post-mortem studies is that the condition that killed the 
individual may itself have affected adipose tissue distribution, giving some uncertainty as to 
what actually constitutes ‘normal’. Even when samples can be obtained from live patients, 
they are usually small and may allow only the analysis of mRNA levels, not the actual 
expressed protein levels. For ethical reasons it is currently difficult to obtain control patients, 
although this may change with the advent of large-scale prospective studies. 
Going beyond the identification and quantitation of EAT, many studies of the depot have 
involved molecular and biochemical studies using either blood or tissue biopsies, obtained 
during elective cardiovascular surgery procedures. These studies have variously used ELISA 
(Mazurek et al., 2003; Gao et al., 2011; Sacks et al., 2011; Teijeira-Fernandez et al., 2011; 
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Fosshaug et al., 2015; Venteclef et al., 2015; Elie et al., 2016), PCR (Mazurek et al., 2003; 
Fain et al., 2010; Gao et al., 2011; Teijeira-Fernandez et al., 2011; Fosshaug et al., 2015), 
miR analysis (Vacca et al., 2016), transcriptome and secretome analysis (Guauque-Olarte et 
al., 2011; Imoto-Tsubakimoto et al., 2013; Gaborit et al., 2015; McAninch et al., 2015; 
Venteclef et al., 2015) to show that the molecular profile of EAT is different from that of 
other adipose depots, and can change during physiological challenges affecting the heart. 
This large body of data supports the site-specific, localised role played by EAT, but does not 
elucidate the question of whether the observed changes are the cause or the effect of 
physiological disturbance. In order to get around this problem a model system amenable to 
experimental manipulation is required. Although clinicians are frequently unwilling to 
translate data derived from animal studies to humans, it remains the case that whole animals, 
or cells derived from them, constitute a rich source of information and data, and can 
frequently provide valid experimental models. We discuss some of the options below. 
 
Studying EAT-cardiac myocyte interactions using animal models 
Some of the earliest studies of EAT (Marchington et al., 1989; Marchington et al., 1990) 
used short-term cultures of tissue explants from rodents to study the biochemistry and fat 
trafficking in epicardial adipocytes. Animal tissue has also been cultured for this purpose by 
Greulich et al. (2011) (guinea pigs and rats), Chilukoti et al. (2015) (pigs and rats), and Lage 
et al. (2015) (neonatal rats and cell lines). The availability of a range of mouse knock-out 
strains has also been exploited by Nevelsteen et al. (2013), studying cardiac myocyte 
function and obesity, though not specifically EAT, and by Castro et al. (2015). This group 
reported on a wide-ranging project in which they studied the metabolomics by MS-NMR and 
looked at circadian rhythms of brown and white adipose tissue.  
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In an attempt to elucidate the role of adipokines in cardiac dysfunction, many in vitro studies 
have added purified adipokines to cardiac myocytes in culture, and measured the effects on 
their function. A drawback of these studies is that the adipokine effects may be complex and 
are often concentration-dependent (see above): for example the cardioprotective effect of 
omentin-1 is only evident when applied in combination with inflammatory interleukins 
(Greulich et al., 2013). It is not easy to replicate in culture relevant physiological conditions, 
in which there may be subtle differences in adipokine and other cytokine concentrations. One 
approach to resolving this problem has been to use ex vivo cultured EAT biopsy samples to 
prepare conditioned media for adding to established cultures of (usually) rodent cardiac 
myocytes. Such an approach has been used to analyse the secretome, and to test for structural 
and functional effects of the EAT on the cardiac myocytes. Such studies identified activin A 
as the major factor causing fibrosis (Venteclef et al., 2015). 
 
It is known that both a high fat diet and diabetes mellitus cause deterioration in heart 
function. Medium conditioned by the EAT of animals eating a high fat diet recapitulated 
these effects (reduced contraction strength and Ca
2+
 amplitude in isolated rat cardiac 
myocytes), whilst medium conditioned by SAT did not (Greulich et al., 2011). In a later 
study, the authors found that the reduced cardiac function was caused by a lack of omentin-1, 
which in healthy animals protects the cardiac myocytes from the detrimental effects of 
cytokines like interleukins. Omentin-1 cannot fulfil this function when its levels are reduced 
in diabetes mellitus type 2 (Greulich et al., 2013). Other cardioprotective effects of omentin-1 
have been mentioned in Table 1. Another adipokine that impairs cardiac function, specifically 
the cardiac myocyte’s contractility, is FABP4, which was identified and its effects 
characterised by Lamounier-Zepter et al. (2009 and 2014). The detrimental effects of FABP4 
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are potentiated in the presence of epoxyeicosatrienoic acids, which are also secreted by the 
EAT.  
 
Although many such studies have elucidated the role of EAT and related it to cardiac 
function, little has yet been done to elucidate the physiological interplay between these 
tissues. In order to do this rigorously a culture methodology that is robust, reproducible and 
physiologically relevant must be adopted. Conventional two-dimensional (2D) culture can be, 
and has been, used but although it offers the opportunity for extensive experimental 
manipulations it is a poor representation of the in vivo physiological situation. Whilst a 
cardiac myocyte culture, using neonatal cells, is relatively straightforward to set up, it is 
difficult to mimic any effects of neighbouring adipocytes. Using adipocyte-conditioned 
media, as described above, means that cardiac myocytes are presented with a bolus of 
adipocyte-derived molecules, which, although more representative than the addition of 
isolated adipokines, are nevertheless likely to be at different concentrations from those 
present in the paracrine flow that occurs in vivo. In addition, labile molecules will not be 
adequately represented in conditioned medium, so their effects can be missed. From a clinical 
perspective it is necessary to find treatments that allow the long-term management of 
adipocyte-cardiac myocyte interactions. Acute responses evoked by bolus additions of 
adipocyte-conditioned medium can pinpoint factors that affect cardiac myocyte function, but 
it is not a method that allows prolonged study, and management, of cardiac myocyte 
functionality and viability in the presence of persistent paracrine signals. For these reasons, 
we consider that a better method for studying interactions between cell types may be to use 
three-dimensional (3D) co-cultures, and we elaborate on this below. 
 
The 3D approach 
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Primary adipocytes are difficult to work with in vitro, as they are very fragile. They cannot be 
retained in 2D cultures because their buoyant density decreases as they accumulate 
triacylglycerols, causing them to detach from the culture substrate and become lost during 
medium changes. Furthermore, only cardiac myocytes prepared from neonatal rodents can be 
kept in culture for prolonged periods of time, as cardiac myocytes isolated from adult animals 
de-differentiate quickly after being isolated and placed in 2D culture. However in 3D culture 
it is possible to keep cardiac myocytes differentiated and spontaneously beating for a period 
of up to 6 weeks (Burridge et al., 2014). Their phenotype resembles that of a mature 
differentiated myocyte when they are kept in a 3D culture that has a stiffness mimicking that 
of the heart (Engler et al., 2008; Pontes Soares et al., 2012; Bian et al., 2014). Similarly, 
adipocytes show good survival in 3D cultures, and retain the in vivo structural and functional 
characteristics of mature adipocytes (Daya et al., 2007). Because collagen gels are 
translucent, 3D co-cultures are amenable to microscopic analyses that allow real-time 
measurement of cellular responses and phenotype. Contractions of the whole gel or of cells 
inside the gel can be measured by force transducers or by visualising cell contraction, and 
intracellular Ca
2+
 changes can be monitored using fluorescent Ca
2+
 sensitive dyes (Shapira-
Schweitzer et al., 2009; Ye, 2011; Bian et al., 2014; Chiu et al., 2014). Furthermore, the 
culture supernatants can be assayed for secreted molecules, and the two cell types can be 
independently recovered for proteomic, genomic and molecular analysis (Daya et al., 2007; 
Phillips et al., 2011; Georgiou et al., 2015). Thus primary cardiac myocytes and adipocytes 
can be co-cultured for prolonged periods of time, allowing paracrine signalling to occur, and 
the interactions between these cells to become established in a way that closely models the in 
vivo situation. The functionality and viability of cells within the 3D collagen matrix can be 
closely monitored, and both cell types can be recovered separately for subsequent in vitro 
molecular analysis. By culturing adipocytes and cardiac myocytes within a 3D co-culture 
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model we can better mimic the normal concentrations and rates of paracrine delivery of 
signals between these cells.  
 
Conclusions 
Epicardial adipose tissue is now well established as an important modulator of cardiac 
function. Changes in EAT metabolism can be associated with a number of pathologies both 
in human patients and in animal models, and it seems clear that this relationship is a strong 
candidate for therapeutic intervention. However the relationship is a complex one: not only 
does the particular mix of paracrine signals vary with physiological state, but the anatomical 
location within the EAT appears to play a part as well. Like all adipose tissue, EAT 
demonstrates site-specific functionality.  
 
Although there have been many important contributions towards elucidating the interplay 
between cardiac myocytes and EAT, more questions remain unanswered. Key to identifying 
the underlying mechanism(s) is the deployment of appropriate experimental techniques that 
will allow experimental manipulation of the relationship over the short and medium term. 
Only then will it be apparent whether the changes seen in EAT metabolic activities are the 
cause or the result of the pathologies. Current technologies range from the ‘snapshots’ 
provided by imaging and analysis of biopsy samples from patients through to highly 
reductionist in vitro techniques. One limitation of human studies will always be the lack of 
‘healthy EAT’ samples as a control. Our preference is to develop a 3D co-culture system in 
which both cardiac myocytes and adipocytes can flourish together over several weeks, and in 
which experimental modifications and subsequent analysis are straightforward. 
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Table 1 Cardiovascular effects of adipocytokines secreted by EAT. This table summarises 
publications describing effects of adipokines secreted from EAT. +, positive effects; ±, 
positive and negative effects; -, negative effects on cardiovascular function.  [Please also see 
separate document for the table in landscape format, our preferred formatting option.] 
 
Name Observation Methodology Overal
l effect  
Reference 
General 
inflammatory 
adipokines 
EAT secretes pro-inflammatory 
cytokines (TNFα, MCP1, IL-1, IL-1β, 
IL-1 Ra, IL-6, IL-8, PAI-1, CRP, 
haptoglobin) which are all linked to 
coronary artery disease (CAD). NFκB 
upregulated in inflammatory states 
Review articles.  - (Mazurek et al., 
2003) 
(Gaborit et al., 
2013) 
Adiponectin Improves endothelial function via 
endothelial NO synthase (eNOS) 
 
 
In obesity, reduces oxidative stress, 
further protecting the endothelium 
Isolated aortic tissue from rats on normal vs. 
high fat diet. Adiponectin addition. eNOS and 
iNOS responses in vascular tissue were 
characterised.  
Responses of rat aortic tissue and human aortic 
endothelial cells to adiponectin addition were 
characterised (endothelial function, eNOS). 
+ (Li et al., 2007) 
 
 
 
(Deng et al., 
2010a) 
 Improves the redox state in blood 
vessels by restoration of eNOS coupling 
Human adipose tissue samples (perivascular, 
subcutaneous and mesothoracic), endothelium 
from matching vein and arteries.  Adiponectin 
+ (Margaritis et al., 
2013) 
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gene expression and vascular responses to eNOS 
were characterised.  
 Decreased levels in obesity Abdominal and epicardial adipose tissue from 
humans.   
CT study in humans (atherosclerosis patients). 
Adipokine plasma levels were measured.    
- (Cheng et al., 
2008) 
 
(Greif et al., 2009) 
 Recombinant adiponectin can 
successfully reverse some harmful 
effects of EAT-derived factors  
EAT samples from human CAD patients ± 
diabetes. Conditioned medium, effects on THP-1 
cells and endothelial cells were characterised.  
+ (Karastergiou et 
al., 2010) 
 Generally cardioprotective, 
downreglated in CAD and heart failure 
Review article ± (Iacobellis, 2015) 
 Decreased in CAD 
Possible negative effects in elderly 
heart-failure patients 
Review article - (Gaborit et al., 
2013) 
 Rescues reduced contractility, reduces 
the speed of contraction and increases 
peak Ca2+ in cardiac myocytes from 
LepRdb/db mice. No effects on lean 
control mice 
Isolated cardiac myocytes from LepRdb/db mice 
& lean control mice. Responses to adiponectin.  
+ (Dong et al., 2009) 
 Reduced secretion in presence of 
macrophages, except in the presence of 
EPA  
In vitro co-culture of adipocytes and 
macrophages from ob/ob mice, high fat diet and 
control mice; EPA treatment. Adiponectin 
concentration in human plasma from obese 
patients, ± EAT.   
- (Itoh et al., 2007) 
 Anti-hypertrophic Whole rat hearts, Langendorff prep.  
Conditioned medium from isolated adipocytes 
and pure cytokines. Effects on contractility. 
+ (Look et al., 2011) 
 Inversely correlated with atherosclerosis Human periaortic, pericoronary and apical EAT 
samples. Adipokine expression. 
+ (Spiroglou et al., 
2010) 
FABP4 Suppresses cardiac myocyte 
contractions 
Isolated rat cardiac myocytes, FABP4 effects on 
myocyte function. 
Isolated rat cardiac myocytes. Adipocyte 
conditioned medium. Addition of isolated 5,6-
EET and FABP4; effects on cardiac function. 
- (Lamounier-Zepter 
et al., 2009) 
(Lamounier-Zepter 
et al., 2014) 
 Associated with left ventricular 
dysfunction in obese subjects 
Human obese patients ± left ventricular 
dysfunction. Adipokine levels and ventricular 
diastolic function measured. 
- (Baessler et al., 
2014) 
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 Pro-inflammatory Review article.  - (Xu et al., 2012) 
 Supresses cardiac myocyte function; 
intracellular uptake of FA and 
intracellular transport; upregulated in 
EAT from patients with metabolic 
syndrome 
EAT and ascending aorta tissue samples from 
human metabolic syndrome patients. FABP4 
expression.  
 (Vural et al., 2008) 
FABP3 Increased levels in EAT (but not SAT) 
from heart failure patients 
SAT and EAT biopsies from human heart failure 
and control patients. Plasma adipokine levels 
were measured.  
- (Fosshaug et al., 
2015) 
 Suppresses cardiac myocyte 
contractions 
Isolated rat cardiac myocytes, FABP4 effects on 
myocyte function were examined.  
 (Lamounier-Zepter 
et al., 2009) 
Activin A Pro-fibrotic Human EAT and SAT biopsies, fibrotic 
properties on organo-culture models of rat atria.  
- (Venteclef et al., 
2015) 
 Upregulated in animals eating a high fat 
diet  
EAT and SAT from guinea pigs on high fat vs. 
normal diet to prepare conditioned media. 
Tested for their effects on contractile function 
and insulin secretion in rat cardiac myocytes.  
- (Greulich et al., 
2011) 
 Positively associated with atrial 
fibrillation 
Editorial 
Review article 
- (Hatem, 2014) 
(Hatem et al., 
2014) 
 Reduces cardiac myocyte contractility 
by reducing Ca2+ flux 
EAT biopsies from human diabetes mellitus 
patients and controls used to prepare conditioned 
medium. Adipokine measurements and effects 
on contractile function and insulin secretion in 
rat cardiac myocytes. 
- (Greulich et al., 
2012) 
 Increased levels in patients with low left 
ventricular function 
Human EAT and SAT biopsies, fibrotic 
properties on organo-culture models of rat atria. 
- (Venteclef et al., 
2015) 
Adreno- 
medullin 
Cardioprotective EAT and SAT samples from human CAD 
patients and controls. Adrenomedullin 
expression was measured.  
+ (Silaghi et al., 
2007) 
 Reduced mRNA and protein levels in 
CAD 
EAT samples from human CAD patients and 
controls. Adrenomedullin levels were measured.  
+ (Iacobellis et al., 
2009a) 
 Increased mRNA in patients with CAD Blood, EAT and SAT from human CAD patients 
and controls. Adipokine levels were measured.  
- (Shibasaki et al., 
2010) 
 Increased levels in EAT but not SAT 
from heart failure patients 
SAT and EAT biopsies and plasma samples 
from human heart failure patients and controls. 
Adipokine levels were measured. 
 (Fosshaug et al., 
2015) 
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Omentin-1 Anti-inflammatory and promotes insulin 
sensitivity.  
Improves endothelial function, and 
reperfusion after ischaemia, by 
increasing the production of nitric oxide 
by eNOS.  
Human EAT and SAT samples, gene expression 
was characterised.  
+ (Gaborit et al., 
2015) 
 Plasma level decreases in obesity and in 
type 2 diabetes.   
EAT biopsies from human diabetes mellitus 
patients and controls used to create conditioned 
medium. Omentin-1 levels and effects on 
contractile function and insulin secretion in rat 
cardiac myocytes were measured. 
+ (Greulich et al., 
2013) 
 mRNA and protein expression increased 
in patients with CAD, particularly from 
EAT around areas of stenosis 
Plasma, SAT and EAT samples in human CAD 
patients and controls. Adipokine levels were 
measured.  
 (Du et al., 2016) 
Leptin Reduces endothelial-dependent 
vasodilation 
Rat, leptin effects on blood pressure were 
characterised. 
- (Bełtowski et al., 
2004) 
 Increased in obesity Abdominal and epicardial adipose tissue from 
human atherosclerosis patients.  
CT study; plasma levels of adipokines were 
measured.  
- (Cheng et al., 
2008) 
 
(Greif et al., 2009) 
 Chemo attractive to monocytes THP-1 macrophages from LepRdb/db and LepR+/+ 
mice. Responses to purified leptin and MCP-1 
were characterised.  
- (Gruen et al., 
2007) 
 Decreases high density lipoproteins and 
apolipoprotein A1 concentrations  
Correlation of leptin and HDL levels in healthy 
humans.  
- (Rainwater et al., 
1997) 
 Activates C-reactive protein (CRP) and 
serum amyloid A  
Correlation study of BMI and serum adipokine 
levels in healthy humans. 
- (Kazumi et al., 
2003) 
 Increases oxidative stress, inflammation 
and smooth muscle proliferation, 
recruits monocytes and via macrophages 
accelerates the formation of foam cells 
Review article - (Matloch et al., 
2016) 
 Rapidly induces hypertrophy in cultured 
neonatal rat ventricular myocytes  
Neonatal rat ventricular myocytes. Leptin 
addition. Measurement of hypertrophy.  
- (Rajapurohitam et 
al., 2003) 
 Increases blood pressure and heart rate 
via sympathetic nervous system 
stimulation and causes hypertension 
Fasting leptin plasma levels in humans with 
hypertension were measured.  
- (Paolisso et al., 
1999) 
 Physiological doses abolish the negative Rat models of ischemia/reperfusion injury ± + (Smith et al., 2010) 
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inotropic effects of IL-1β and can 
protect from reperfusion injury 
leptin administration were examined.  
 Reduce endothelial-dependent 
vasodilation 
Rat, leptin effects on blood pressure were 
measured.  
- (Bełtowski et al., 
2004) 
Resistin Circulating levels increased in obesity Abdominal and epicardial adipose tissue from 
human atherosclerosis patients.  
CT study; plasma levels of adipokines were 
measured. 
- (Cheng et al., 
2008) 
 
(Greif et al., 2009) 
 Promotes cardiac hypertrophy in rodents  Neonatal rat ventricular myocytes and adult rat 
cardiac myocytes. Resistin overexpression. 
Cardiac function and signalling pathways were 
examined.  
- (Kim et al., 2008) 
 Impairs endothelial function Review article - (Pang et al., 2006) 
 Increased circulating levels in heart 
failure and myocardial infarction 
Human myocardial infarction, ischemic stroke 
patients and controls. Plasma resistin levels were 
measured.  
Human HF patients, adipokine levels in blood 
samples were measured.  
- (Weikert et al., 
2008) 
 
 
(Frankel et al., 
2009) 
 Associated with atherosclerosis, 
myocardial infarction and coronary 
artery disease 
Adipokine secretion in EAT from human acute 
coronary syndrome vs. CAD patients.  
Human myocardial infarction patients. Blood, 
EAT and SAT samples. Resistin levels were 
measured.  
- (Langheim et al., 
2010) 
 
(Rachwalik et al., 
2014) 
Apelin Positive inotrophic effect in normal and 
failing myocardium. Protective against 
ischemia and reperfusion injury in rats 
Rat hearts, pressure overload models and 
isolated neonatal rat ventricular myocytes. 
Apelin effects on cardiac function were 
measured.  
Ischemic reperfusion injury rat model, effects of 
apelin addition were examined.  
Heart failure control rats, cardiac function after 
apelin addition was characterised.  
+ (Szokodi, 2002) 
 
 
(Berry et al., 2004) 
 
(Kleinz et al., 
2008) 
 Positively correlated with obesity; 
promotes a cardioprotective response 
Apelin-receptor KO mice, characterisation of 
cardiac function.  
+ (Scimia et al., 
2012) 
 Stimulates contractility in cardiac 
myocytes 
Rat hearts, pressure overload models and 
neonatal rat ventricular myocytes. Apelin effects 
on cardiac function were examined.  
+ (Szokodi, 2002) 
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 Exogenous apelin has anti-inflammatory 
effects and reduces the formation of 
aortic aneurisms 
Mouse aortic aneurysm model ± apelin. 
Adipokine expression in macrophages, smooth 
muscle cells and fibroblasts was measured.  
+ (Leeper et al., 
2009) 
Vaspin Correlated with atherosclerosis in a site-
specific way 
Human periaortic, pericoronary and apical EAT 
samples. Adipokine expression was measured. 
- (Spiroglou et al., 
2010) 
 Circulating levels correlated with 
reduced cardiac flow reserve 
Human nonalcoholic fatty liver disease patients. 
Measurement of EAT thickness, coronary flow 
reserve and chemerin and vaspin serum levels.  
- (Yilmaz et al., 
2011) 
Visfatin Site-specific expression within EAT, 
increased in patients with 
atherosclerosis 
Human periaortic, pericoronary and apical EAT 
samples. Adipokine expression was measured. 
- (Spiroglou et al., 
2010) 
 Proinflammatory; produces endothelial 
dysfunction 
Human diabetes patients and controls. Plasma 
visfatin levels. Endothelial function was 
measured.  
- (Takebayashi et 
al., 2007)  
 Exogenous visfatin reduces cell death 
and myocardial infarct size after 
reperfusion 
Mouse ischemia/reperfusion injury model ± 
visfatin. Isolated myocytes in hypoxia ± visfatin. 
Signalling pathways and mitochondrial function 
were measured.  
+ (Lim et al., 2008) 
Chemerin Positive correlation with atherosclerosis Human periaortic, pericoronary and apical EAT 
samples. Adipokine expression was measured. 
- (Spiroglou et al., 
2010) 
 mRNA and protein expression increased 
in patients with CAD 
EAT and SAT and serum samples from human 
CAD patients and controls. Adipokine levels 
were measured.  
- (Gao et al., 2011) 
 Induces apoptosis in mouse cardiac 
myocytes in culture 
Mouse cardiac myocytes; insulin and TNF-α 
treatment. CMKLR1 and chemerin expression 
were measured.  
- (Rodriguez-Penas 
et al., 2015) 
Orosomucoid At low levels, orosomucoid secretion 
from EAT protects cultured cardiac 
myocytes from apoptosis due to hypoxia  
At high levels orosomucoid is a risk 
factor for myocardial infarction and 
heart failure.  
EAT samples from human biopsies were used to 
prepare conditioned medium. Rat cardiac 
myocyte cell line (H9C2) and neonatal rat 
ventricular myocytes. Effects on cell viability ± 
hypoxia were measured.  
±  (Lage et al., 2015) 
 Increasing endothelial cell proliferation, 
promotes healing of damaged endothelia 
EAT and SAT samples from type 2 diabetes 
mellitus patients used to prepare conditioned 
medium. Adipokine secretion after isoproterenol 
stimulation and effects of conditioned medium 
measured on endothelial cell function and 
+ (Fandino-Vaquero 
et al., 2014) 
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wound healing were measured.  
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Ligands   
Leptin 
 
FABP4 
 
Adrenomedullin - human 
Adiponectin 
 
 
FABP3 
 
Adrenomedullin - mouse 
Chemerin 5,6-EET 
 
Adrenomedullin - rat 
   
   
 
Targets  
Leptin receptor 
 
Apelin receptor 
Adipo1 receptor Chemerin receptor 
Adipo2 receptor  
 
Families 
Adiponectin receptor 
Fatty acid-binding 
proteins 
Chemerin 
receptor 
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Figure 1 Diagram illustrating the positions of epicardial and pericardial fat depots in 
the heart. Note the intimate association between the epicardial fat and the myocardium. 
Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews Endocrinology. 
(Iacobellis, G. (2016) Nat Rev Endocrinol 11(6): 363-71). Copyright (2016). 
  
  EAT and cardiac myocytes 
 
This article is protected by copyright. All rights reserved. 
 
Figure 2 Model of potential interactions between cardiac excitation-contraction 
coupling and EAT. The figure illustrates places where adipokines might affect the 
excitation-contraction coupling of cardiac myocytes. Panel A shows the excitation-
contraction coupling in cardiac myocytes in a healthy situation. Arrival of an action potential 
(ΔVM) opens voltage-gated Ca2+ channels in the sarcolemma, causing the influx of Ca2+ 
ions. The increase in the intracellular Ca2+ concentration activates Ca2+-activated Ca2+-
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release via ryanodine receptors localised on the sarcoplasmic reticulum (SR), causing the 
myocyte to contract. Adipocytes in the EAT are in contact with the cardiac myocytes, and 
can reach between them. They secrete e.g. omentin-1, apelin and adiponectin, which act on 
the cardiac myocytes in a positive manner, sustaining their regular contractions. They also 
affect processes other than the myocyte’s contraction, e.g. gene expression, anti-
inflammatory functions, and protection from reactive oxygen species (ROS). Panel B shows 
changes occurring in a disease situation, where the secretome from the EAT is remodelled. 
Adipocytes infiltrate deeper between the myocytes and release different adipokines, e.g. 
activin A, leptin and FABP4. Activin A activates fibrosis, which in turn hinders the smooth 
propagation of action potentials and can cause pro-arrhythmic re-entry circuits. FABP4 and 
apelin reduce the myocyte’s contraction strength. Adipokines can increase intracellular ROS 
production, causing spontaneous Ca2+ release from the SR, further contributing to 
arrhythmia. Adipokines in a diseased state cause a pro-inflammatory situation, including the 
recruitment and activation of macrophages, and change the pattern of gene expression. 
Several of the signalling pathways and receptors activated by adipokines are not yet 
identified. 
 
